PH12005500143B1 - Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids - Google Patents

Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Info

Publication number
PH12005500143B1
PH12005500143B1 PH12005500143A PH12005500143A PH12005500143B1 PH 12005500143 B1 PH12005500143 B1 PH 12005500143B1 PH 12005500143 A PH12005500143 A PH 12005500143A PH 12005500143 A PH12005500143 A PH 12005500143A PH 12005500143 B1 PH12005500143 B1 PH 12005500143B1
Authority
PH
Philippines
Prior art keywords
alpha
hydroxysteroids
substituted
production
microbiological method
Prior art date
Application number
PH12005500143A
Inventor
Ludwig Zorn
Rolf Bohlmann
Norbert Gallus
Hermann Kunzer
Hans-Peter Muhn
Reinhard Nubbemeyer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of PH12005500143B1 publication Critical patent/PH12005500143B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/06Hydroxylating
    • C12P33/08Hydroxylating at 11 position
    • C12P33/10Hydroxylating at 11 position at 11 alpha-position
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/12Acting on D ring
    • C12P33/16Acting at 17 position
PH12005500143A 2002-07-24 2005-01-21 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids PH12005500143B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (en) 2002-07-24 2002-07-24 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids
US40295302P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
PH12005500143B1 true PH12005500143B1 (en) 2011-03-25

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12005500143A PH12005500143B1 (en) 2002-07-24 2005-01-21 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Country Status (20)

Country Link
EP (1) EP1523568A2 (en)
JP (1) JP4417838B2 (en)
KR (1) KR101041328B1 (en)
CN (1) CN100339486C (en)
BR (1) BR0313210A (en)
CA (1) CA2492079C (en)
CO (1) CO5690563A2 (en)
CR (1) CR7672A (en)
EA (2) EA008147B1 (en)
EC (1) ECSP055630A (en)
HK (1) HK1081999A1 (en)
HR (1) HRP20050172A2 (en)
IL (1) IL166358A0 (en)
MX (1) MXPA05001024A (en)
NO (1) NO20050980L (en)
NZ (2) NZ549529A (en)
PH (1) PH12005500143B1 (en)
PL (1) PL373808A1 (en)
RS (1) RS51855B (en)
WO (1) WO2004011663A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101296936B (en) * 2005-10-27 2011-06-22 大鹏药品工业株式会社 Process for production of steroid compound
CN103834712B (en) * 2012-11-26 2016-03-30 复旦大学 The optimization method of desogestrel intermediate nanometer liposome bio-transformation
CN103214543B (en) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 New Crategolic acid derivative, its preparation method and the application in antitumor drug thereof
CN104862323B (en) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 Modify the '-hydroxylase gene of diphenol compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE496261A (en) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167380A3 (en) 1995-12-11 2004-12-08 G.D. Searle & Co. 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
KR19990072066A (en) * 1995-12-12 1999-09-27 이.에이치. 리링크 11α-hydroxylation of Steroids by Microorganisms
US20020012694A1 (en) 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE60127103T2 (en) 2000-02-15 2007-11-22 Bayer Schering Pharma Ag COMPOSITION FOR MALE CONCENTRATION, NORETHISTERONE AND TESTOSTERONE ANDECANOATE CONTAINING
DE10104327A1 (en) * 2001-01-24 2002-07-25 Schering Ag New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control
JP2006502997A (en) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト Composition containing androgen 11.beta.-halogen steroid and gestagen and male contraceptive based on this composition

Also Published As

Publication number Publication date
HK1081999A1 (en) 2006-05-26
AU2003281677A1 (en) 2004-02-16
CN100339486C (en) 2007-09-26
RS51855B (en) 2012-02-29
WO2004011663A2 (en) 2004-02-05
EP1523568A2 (en) 2005-04-20
NZ549529A (en) 2008-04-30
CA2492079A1 (en) 2004-02-05
HRP20050172A2 (en) 2005-04-30
NZ537871A (en) 2006-10-27
WO2004011663A9 (en) 2004-05-06
EA008147B1 (en) 2007-04-27
EA200500224A1 (en) 2005-08-25
KR101041328B1 (en) 2011-06-14
NO20050980L (en) 2005-02-23
PL373808A1 (en) 2005-09-19
JP4417838B2 (en) 2010-02-17
CA2492079C (en) 2012-01-10
EA200601030A1 (en) 2006-10-27
CO5690563A2 (en) 2006-10-31
MX260952B (en) 2008-10-01
IL166358A0 (en) 2006-01-16
JP2006503813A (en) 2006-02-02
CR7672A (en) 2006-05-29
CN1671858A (en) 2005-09-21
RS20050045A (en) 2007-06-04
ECSP055630A (en) 2005-04-18
EA010572B1 (en) 2008-10-30
WO2004011663A3 (en) 2004-07-15
KR20050026507A (en) 2005-03-15
BR0313210A (en) 2005-06-28
MXPA05001024A (en) 2005-05-16

Similar Documents

Publication Publication Date Title
ZA200605864B (en) Method for the production of methionine
AU2003219592A1 (en) Chiral intermediate and process for the production thereof
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2003293895A1 (en) Method for the production of isocyanates
PL377943A1 (en) Method for the production of benzophenones
HK1081999A1 (en) Microbiological method for the production of 7 alpha-substituted 11 alpha-hydrox-ysteroids
IL158400A0 (en) Process for the production of citalopram
AU2003293477A1 (en) Method for the production of polycarbonates
GB0216311D0 (en) An improved process for the production of substituted thioxanthones
AU2003293272A1 (en) Method for the production of bioprostheses
HUP0401111A3 (en) Microbiological method for producing amides
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
IL162770A0 (en) Process for the preparation methylsteroids of 7
AU2003292209A8 (en) Method for the production of optically active dihydropyrones
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes
AU2003281677B2 (en) Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
IL158119A0 (en) Method for the production of delta1-pyrrolines
IL166631A0 (en) Process for the production of bisphenol-a
EP1553073A4 (en) Process for production of 1,2,4-butanetriol
AU2003245879A1 (en) Method for the production of substituted trifluoroetylenes
IL164437A0 (en) Method for the production of 2,4,5-trimethylphenylacetic acid
AU2003283245A8 (en) Method for the production of 1,6-hexanediol
AU2003264134A1 (en) Sarcolysyl derivatives and method for the production thereof
AU2003233239A1 (en) Method for the production of polymethylenepolysulfides